Carlos Nueno - 27 Feb 2026 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Mar 2026, 16:10:50 UTC
Prior SEC filing
03 Dec 2025
Next SEC filing
03 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Adam C. Vandervoort, Attorney-in-Fact

Key filing fact

Carlos Nueno filed Form 4 for Teladoc Health, Inc. (TDOC) on 03 Mar 2026.

Key facts

  • This page summarizes Carlos Nueno's Form 4 filing for Teladoc Health, Inc. (TDOC).
  • 10 reported transactions and 5 derivative rows are listed below.
  • Accepted by SEC: 03 Mar 2026, 16:10.

Change

  • Previous filing in this sequence was filed on 03 Dec 2025.
  • Current net transaction value: -$103,184.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002037711 Primary reporting owner

Nueno Carlos

Relationship
President, International
Address
C/O TELADOC HEALTH, INC.,, 155 E 44TH ST, SUITE 1700, NEW YORK
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Signature date
03 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TDOC transaction

Common Stock

Options Exercise

Transaction value
Shares
+3,101
Change %
+11%
Price
Shares after
30,276
Date
27 Feb 2026
Ownership
Direct
Footnotes
F1
TDOC transaction

Common Stock

Options Exercise

Transaction value
Shares
+4,556
Change %
+15%
Price
Shares after
34,832
Date
27 Feb 2026
Ownership
Direct
Footnotes
F1
TDOC transaction

Common Stock

Options Exercise

Transaction value
Shares
+34,867
Change %
+100%
Price
Shares after
69,699
Date
27 Feb 2026
Ownership
Direct
Footnotes
F1
TDOC transaction

Common Stock

Options Exercise

Transaction value
Shares
+1,061
Change %
+1.5%
Price
Shares after
70,760
Date
27 Feb 2026
Ownership
Direct
Footnotes
F2
TDOC transaction

Common Stock

Sale

Transaction value
$103,184
Shares
-20,165
Change %
-28%
Price
$5.12
Shares after
50,595
Date
02 Mar 2026
Ownership
Direct
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TDOC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-3,101
Change %
-100%
Price
$0.000000
Shares after
0
Date
27 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,101
Exercise price
Footnotes
F1, F4
TDOC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-4,556
Change %
-20%
Price
$0.000000
Shares after
18,226
Date
27 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,556
Exercise price
Footnotes
F1, F5
TDOC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-34,867
Change %
-33%
Price
$0.000000
Shares after
69,735
Date
27 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
34,867
Exercise price
Footnotes
F1, F6
TDOC transaction Derivative

Performance Stock Units

Options Exercise

Transaction value
$0
Shares
-1,061
Change %
-100%
Price
$0.000000
Shares after
0
Date
27 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,061
Exercise price
Footnotes
F2, F7
TDOC transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+173,010
Change %
Price
$0.000000
Shares after
173,010
Date
01 Mar 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
173,010
Exercise price
Footnotes
F8, F9
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 9 footnotes

Footnote F1

Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Footnote F2

Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

Footnote F3

Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.

Footnote F4

On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Footnote F5

On March 19, 2024, the reporting person was granted 54,675 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.

Footnote F6

On March 1, 2025, the reporting person was granted 104,602 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Footnote F7

On March 1, 2024, the reporting person earned 12,679 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Footnote F8

Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.

Footnote F9

One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .